Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes

This study was registered at www.clinicaltrials.gov as #NCT02101138.

Source: Blood - August 2, 2018 Category: Hematology Authors: Panch, S. R., Bozik, M. E., Brown, T., Makiya, M., Prussin, C., Archibald, D. G., Hebrank, G. T., Sullivan, M., Sun, X., Wetzler, L., Ware, J., Fay, M. P., Dunbar, C. E., Dworetzky, S. I., Khoury, P., Maric, I., Klion, A. D. Tags: Phagocytes, Granulocytes, and Myelopoiesis, Clinical Trials and Observations Source Type: research